Croma-Pharma
Lukas Einhorn is a Regulatory Affairs Manager at CROMA-PHARMA since 2018, with a strong background in immunology and allergy research acquired during doctoral studies at the Medical University of Vienna from 2013 to 2017. Additionally, Lukas gained international experience through a short-term research program at Tokyo University of Agriculture and Technology in 2016. Previous roles include an analyst position at Boehringer Ingelheim and various trainee positions at leading universities, including University of Natural Resources and Life Sciences, Vienna, and University of Veterinary Medicine Vienna. Academic qualifications include a Diplom-Ingenieur in Biotechnology and a Bachelor of Science in Food and Biotechnology from the University of Natural Resources and Life Sciences, Vienna.
This person is not in any offices
Croma-Pharma
4 followers
Croma is a global player in the minimally invasive aesthetics market and a leading European manufacturer of premium quality hyaluronic acid syringes. The company offers a comprehensive and innovative aesthetics portfolio including botulinum toxin, fillers, lifting threads and biostimulators complemented by its own skincare brand. Founded in 1976 by a pharmacist couple, Croma-Pharma GmbH is a family company headquartered in Austria where it also operates its manufacturing plant. With 550 employees, 13 subsidiaries in Europe and Brazil, two joint ventures and 60 exclusive export partners, it distributes its products in 80 markets globally, including the US, Canada, China, Australia and New Zealand. It also operates as a contract manufacturer in orthopaedics and ophthalmology. For more information please visit cromapharma.com.